Author:
Clair Kiran H.,Gallegos Nicolas,Bristow Robert E.
Funder
National Institutes of Health
Subject
Obstetrics and Gynaecology,Oncology
Reference14 articles.
1. Alazzam, M., Tidy, J., Bw, H., Osborne, R., 2009.First line chemotherapy in low risk gestational trophoblastic neoplasia (Review).
2. FDA’s label for pembrolizumab, 2017.
3. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia;Ghorani;Lancet,2017
4. Goldstein, R., Donald, P. Berkowitz, n.d. Current management of gestational trophoblastic neoplasia.
5. A critical role for the programmed death ligand 1 in fetomaternal tolerance;Guleria;Brief Definit. Rep.,2005
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献